Primary Antibodies
ERG (Clone 9FY) Mouse Monoclonal Antibody
TMPRSS2:ERG is the most prevalent gene rearrangement in prostate cancers leading to overexpression of a truncated ERG protein in a subset of prostate cancers. ERG expression is also reported in high-grade prostatic intraepithelial neoplasia (PIN). Publications suggest that the prevalence of the TMPRSS2:ERG rearrangement in prostate cancer cases ranges from ~25% to 70%. ERG is expressed in many tissues including vascular tumors.
Overview
Host: Mouse
Clone: 9FY
Isotope: IgG1
Species Reactivity: Human. Others not known
Epitope: Not determined
Immunogen: N/A
Molecular Weight: ~55kDa
Positive Control: ERG positive prostate carcinomas, vascular endothelial cells or placenta
Localization: Nuclear
Application: IHC
Products
| SKU | Regulatory Status | Format | Volume | Action |
|---|---|---|---|---|
| MS-1937-P: ERG | IVD | Purified Ab with BSA and Azide | 1 ml | Request a Quote |
Pricing
Request a Quote
Request for a SKU